newsfilter
← Latest News
Business Wire·

Seres Therapeutics Stockholders Issue Open Letter to Board of Directors Regarding Reported Engagement With Nestlé

Express Concern Regarding Report That Seres Allegedly Rebuffed an Outright Takeover Offer from Nestlé for $6.00 - $6.50 Per Share Request that the Board Immediately Provide Stockholders With the Facts Regarding Its